Close this search box.

Chi Li to lead regulatory at Curevo

ARTICLE | Management Tracks

Plus: Zura names Robert Lisicki as CEO, and updates from Faron, IO, PanTher and Precision

By BioCentury Staff 

April 8, 2024 11:43 PM UTC

Vaccine company Curevo Inc. hired Chi Li as chief regulatory officer. Li was chief regulatory officer at Editas Medicine Inc. (NASDAQ:EDIT). Curevo is developing amezosvatein, a vaccine to prevent shingles. 

Zura Bio Ltd. (NASDAQ:ZURA) named Robert Lisicki as CEO and a director, succeeding founding CEO Someit Sidhu, who will remain on the company’s board. Lisicki became president and COO of Zura Bio in January. Zura is developing dual-pathway antibodies to treat autoimmune and inflammatory diseases…